Agilon Health (NYSE:AGL) Stock Jumps 3.3% – Still a Buy?

Agilon Health, Inc. (NYSE:AGL)’s share price rose 3.3% during mid-day trading on Wednesday. The stock traded as high as $85.81 and last traded at $86.1120. Approximately 16,983 shares were traded during trading, a decline of 95% from the average session volume of 331,238 shares. The stock had previously closed at $83.40.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. Citigroup upgraded Agilon Health from a “sell” rating to a “neutral” rating and boosted their price target for the stock from $105.00 to $115.00 in a research note on Monday, August 10th. Benchmark reaffirmed a “buy” rating and issued a $140.00 target price (up from $95.00) on shares of Agilon Health in a research report on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of Agilon Health in a research report on Monday, August 24th. Wells Fargo & Company restated an “overweight” rating and issued a $146.00 price target (up from $141.00) on shares of Agilon Health in a research note on Tuesday, August 11th. Finally, Barclays set a $111.00 price target on shares of Agilon Health and gave the company an “equal weight” rating in a report on Thursday, August 6th. Six equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $102.25.

Agilon Health Trading Down 1.4%

The stock has a market cap of $1.42 billion, a P/E ratio of -5.92 and a beta of 2.98. The firm’s 50 day simple moving average is $89.50 and its two-hundred day simple moving average is $78.88. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.07.

Agilon Health (NYSE:AGL) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.90. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. The company had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.45 billion. As a group, equities research analysts predict that Agilon Health, Inc. will post -2.9 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in AGL. Tidal Investments LLC acquired a new stake in shares of Agilon Health in the 2nd quarter worth about $1,405,000. Rubicon Founders LLC bought a new stake in Agilon Health in the 2nd quarter valued at about $11,290,448. State Street Corp acquired a new position in Agilon Health during the 2nd quarter valued at about $30,024,000. Great Lakes Advisors LLC acquired a new position in Agilon Health during the 2nd quarter valued at about $702,000. Finally, Alpine Global Management LLC bought a new position in Agilon Health in the 4th quarter worth about $84,000.

About Agilon Health

Agilon Health, Inc is a healthcare company that helps primary care physicians transition from traditional fee-for-service medicine to value-based care. The company primarily works with independent physician practices that serve older adults, particularly Medicare Advantage members, with the goal of improving care coordination, patient outcomes and the overall healthcare experience.

Agilon provides a technology and services platform designed to support population health management. Its offerings include data analytics, clinical and administrative workflows, practice management support, care coordination resources and assistance with payer contracting.